Cargando…
Evaluation of 6 Commercial SARS-CoV-2 Serology Assays Detecting Different Antibodies for Clinical Testing and Serosurveillance
BACKGROUND: Serological testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) complements nucleic acid tests for patient diagnosis and enables monitoring of population susceptibility to inform the coronavirus disease 2019 (COVID-19) pandemic response. It is important to understand...
Autores principales: | Nicholson, Suellen, Karapanagiotidis, Theo, Khvorov, Arseniy, Douros, Celia, Mordant, Francesca, Bond, Katherine, Druce, Julian, Williamson, Deborah A, Purcell, Damian, Lewin, Sharon R, Sullivan, Sheena, Subbarao, Kanta, Catton, Mike |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8136026/ https://www.ncbi.nlm.nih.gov/pubmed/34258311 http://dx.doi.org/10.1093/ofid/ofab239 |
Ejemplares similares
-
An update on Covid-19 serology
por: Kinsella, Paul M., et al.
Publicado: (2022) -
Comparative Longitudinal Serological Study of Anti-SARS-CoV-2 Antibody Profiles in People with COVID-19
por: Barrios, Marilou H., et al.
Publicado: (2023) -
Longitudinal evaluation of laboratory-based serological assays for SARS-CoV-2 antibody detection
por: Bond, K.A., et al.
Publicado: (2021) -
Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program
por: Stone, Mars, et al.
Publicado: (2021) -
Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of Coronavirus Disease 2019 in Africa
por: Kogan, Nicole E, et al.
Publicado: (2022)